RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Medipharm Labs Stock

Medipharm Labs ROCE 2024

Medipharm Labs ROCE

-0.37

Ticker

LABS.TO

ISIN

CA58504D1006

WKN

A2N7AA

In 2024, Medipharm Labs's return on capital employed (ROCE) was -0.37, a -29.03% increase from the -0.52 ROCE in the previous year.

Medipharm Labs Aktienanalyse

What does Medipharm Labs do?

MediPharm Labs Corp is a leading company in the cannabis industry, specializing in the production of specialized, high-quality cannabis products. The company was founded in 2015 by founders Pat McCutcheon and Keith Strachan and is headquartered in Barrie, Ontario, Canada. Medipharm Labs ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Medipharm Labs's Return on Capital Employed (ROCE)

Medipharm Labs's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Medipharm Labs's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Medipharm Labs's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Medipharm Labs’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Medipharm Labs stock

What is the ROCE (Return on Capital Employed) of Medipharm Labs this year?

The ROCE of Medipharm Labs is -0.37 undefined this year.

How has the ROCE (Return on Capital Employed) of Medipharm Labs developed compared to the previous year?

The ROCE of Medipharm Labs has increased by -29.03% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Medipharm Labs?

A high Return on Capital Employed (ROCE) indicates that Medipharm Labs has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Medipharm Labs?

A low ROCE (Return on Capital Employed) can indicate that Medipharm Labs has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Medipharm Labs impact the company?

An increase in the ROCE of Medipharm Labs can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Medipharm Labs affect the company?

A decrease in ROCE of Medipharm Labs can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Medipharm Labs?

Some factors that can affect Medipharm Labs's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Medipharm Labs so important for investors?

The ROCE of Medipharm Labs is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Medipharm Labs take to improve the ROCE?

To improve the ROCE, Medipharm Labs can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Medipharm Labs pay?

Over the past 12 months, Medipharm Labs paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Medipharm Labs is expected to pay a dividend of 0 CAD.

What is the dividend yield of Medipharm Labs?

The current dividend yield of Medipharm Labs is .

When does Medipharm Labs pay dividends?

Medipharm Labs pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Medipharm Labs?

Medipharm Labs paid dividends every year for the past 0 years.

What is the dividend of Medipharm Labs?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Medipharm Labs located?

Medipharm Labs is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medipharm Labs kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medipharm Labs from 10/4/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 10/4/2024.

When did Medipharm Labs pay the last dividend?

The last dividend was paid out on 10/4/2024.

What was the dividend of Medipharm Labs in the year 2023?

In the year 2023, Medipharm Labs distributed 0 CAD as dividends.

In which currency does Medipharm Labs pay out the dividend?

The dividends of Medipharm Labs are distributed in CAD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Medipharm Labs

Our stock analysis for Medipharm Labs Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medipharm Labs Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.